Total Payments
$466,052
2024 Payments
$112,505
Companies
30
Transactions
467
Medicare Patients
979
Medicare Billing
$136,275
Payment Breakdown by Category
Consulting$311,905 (66.9%)
Travel$82,519 (17.7%)
Other$55,345 (11.9%)
Food & Beverage$12,683 (2.7%)
Research$3,600 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $311,905 | 98 | 66.9% |
| Travel and Lodging | $82,519 | 129 | 17.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $31,670 | 13 | 6.8% |
| Honoraria | $18,600 | 3 | 4.0% |
| Food and Beverage | $12,683 | 220 | 2.7% |
| Grant | $5,075 | 1 | 1.1% |
| Unspecified | $3,600 | 3 | 0.8% |
Payments by Type
General
$462,452
464 transactions
Research
$3,600
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $90,895 | 135 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $55,030 | 38 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $42,669 | 60 | $0 (2024) |
| Pharmacosmos Therapeutics Inc. | $39,247 | 12 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $38,813 | 30 | $0 (2024) |
| Lilly USA, LLC | $38,638 | 17 | $0 (2024) |
| Amgen Inc. | $30,028 | 30 | $0 (2021) |
| Eli Lilly and Company | $28,400 | 10 | $0 (2024) |
| Novo Nordisk Inc | $24,846 | 9 | $0 (2024) |
| Medtronic, Inc. | $13,451 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $112,505 | 61 | Pharmacosmos Therapeutics Inc. ($26,079) |
| 2023 | $73,099 | 59 | Boehringer Ingelheim Pharmaceuticals, Inc. ($19,860) |
| 2022 | $54,609 | 52 | AstraZeneca Pharmaceuticals LP ($14,550) |
| 2021 | $25,963 | 25 | Merck Sharp & Dohme Corporation ($8,050) |
| 2020 | $79,180 | 61 | Merck Sharp & Dohme Corporation ($20,212) |
| 2019 | $74,738 | 98 | Novartis Pharmaceuticals Corporation ($19,349) |
| 2018 | $31,136 | 68 | Merck Sharp & Dohme Corporation ($14,574) |
| 2017 | $14,821 | 43 | Novartis Pharmaceuticals Corporation ($6,084) |
All Payment Transactions
467 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ROCHE DIAGNOSTICS INTERNATIONAL LTD | — | Consulting Fee | Cash or cash equivalent | $2,600.00 | General |
| 12/18/2024 | ROCHE DIAGNOSTICS INTERNATIONAL LTD | — | Travel and Lodging | In-kind items and services | $234.38 | General |
| 12/18/2024 | ROCHE DIAGNOSTICS INTERNATIONAL LTD | — | Food and Beverage | In-kind items and services | $17.20 | General |
| 12/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Consulting Fee | Cash or cash equivalent | $11,505.00 | General |
| Category: DIABETES | ||||||
| 12/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $140.00 | General |
| Category: DIABETES | ||||||
| 12/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: DIABETES | ||||||
| 12/11/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/27/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $41.66 | General |
| Category: Heart Failure | ||||||
| 11/27/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $39.90 | General |
| Category: Heart Failure | ||||||
| 11/27/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Heart Failure | ||||||
| 11/22/2024 | Eli Lilly and Company | MOUNJARO (Drug) | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| Category: Diabetes | ||||||
| 11/22/2024 | Eli Lilly and Company | MOUNJARO (Drug) | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| Category: Diabetes | ||||||
| 11/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Consulting Fee | Cash or cash equivalent | $3,930.00 | General |
| Category: Cardio-renal | ||||||
| 11/15/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Travel and Lodging | In-kind items and services | $315.81 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/15/2024 | ROCHE DIAGNOSTICS INTERNATIONAL LTD | — | Travel and Lodging | In-kind items and services | $229.00 | General |
| 11/15/2024 | ROCHE DIAGNOSTICS INTERNATIONAL LTD | — | Food and Beverage | In-kind items and services | $159.84 | General |
| 11/15/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $125.58 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $159.60 | General |
| 10/31/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Consulting Fee | Cash or cash equivalent | $2,025.00 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $159.60 | General |
| 10/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $359.53 | General |
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $46.25 | General |
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $30.39 | General |
| 10/18/2024 | Medtronic, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,350.00 | General |
| 10/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $453.72 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PACE-US | Medtronic, Inc. | $3,600 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 182 | 348 | $75,819 | $23,054 |
| 2022 | 5 | 236 | 423 | $94,019 | $27,977 |
| 2021 | 7 | 290 | 614 | $135,522 | $41,385 |
| 2020 | 7 | 271 | 566 | $142,484 | $43,858 |
Total Patients
979
Total Services
1,951
Medicare Billing
$136,275
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 55 | 190 | $33,060 | $11,364 | 34.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 76 | 105 | $26,775 | $7,188 | 26.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 28 | 28 | $9,184 | $2,547 | 27.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 23 | 25 | $6,800 | $1,955 | 28.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 69 | 190 | $33,060 | $10,468 | 31.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 84 | 109 | $27,795 | $7,241 | 26.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 35 | 74 | $18,500 | $5,780 | 31.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 30 | 31 | $8,432 | $2,527 | 30.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 18 | 19 | $6,232 | $1,962 | 31.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 77 | 259 | $45,066 | $14,283 | 31.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 43 | 129 | $32,250 | $10,173 | 31.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 83 | 122 | $31,110 | $8,736 | 28.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 31 | 33 | $10,824 | $3,517 | 32.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 28 | 28 | $7,616 | $2,164 | 28.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 13 | 17 | $5,848 | $1,729 | 29.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 15 | 26 | $2,808 | $784.09 | 27.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 91 | 288 | $72,000 | $23,637 | 32.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 33 | 91 | $15,834 | $5,155 | 32.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 46 | 64 | $22,016 | $4,954 | 22.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 27 | 27 | $13,122 | $4,252 | 32.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 40 | 41 | $11,152 | $3,453 | 31.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 23 | 44 | $4,752 | $1,260 | 26.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 11 | 11 | $3,608 | $1,147 | 31.8% |
About Dr. Robert Mentz, MD
Dr. Robert Mentz, MD is a Internal Medicine healthcare provider based in Durham, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2007. The National Provider Identifier (NPI) number assigned to this provider is 1669670790.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Mentz, MD has received a total of $466,052 in payments from pharmaceutical and medical device companies, with $112,505 received in 2024. These payments were reported across 467 transactions from 30 companies. The most common payment nature is "Consulting Fee" ($311,905).
As a Medicare-enrolled provider, Mentz has provided services to 979 Medicare beneficiaries, totaling 1,951 services with total Medicare billing of $136,275. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease
- Location Durham, NC
- Active Since 07/10/2007
- Last Updated 05/01/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1669670790
Products in Payments
- JARDIANCE (Drug) $71,837
- MONOFERRIC (Drug) $35,290
- VERQUVO (Drug) $22,538
- BYETTA (Drug) $12,299
- ENTRESTO (Drug) $11,861
- INJECTAFER (Drug) $10,543
- Corlanor (Drug) $9,130
- FARXIGA (Drug) $6,343
- CD cobas Reagents (Device) $6,153
- MK-1242 (Drug) $5,754
- MOUNJARO (Drug) $5,200
- remede System (Device) $4,800
- Kerendia (Drug) $4,530
- Monoferric (Drug) $3,957
- CARDIOINSIGHT (Device) $3,696
- HeartMate 3 Left Ventricular Assist Device (Device) $2,433
- Circulatory Support (Device) $2,156
- HeartMate 3 Left Ventricular Dev (Device) $2,121
- LifeVest (Device) $2,000
- SOTAGLIFLOZIN (Drug) $919.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Durham
Nirmish Shah, Md, MD
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M
Dr. Stephen Greene, M.d, M.D
Internal Medicine — Payments: $509,299
Internal Medicine $509,299
Dr. John Strickler, Md, MD
Internal Medicine — Payments: $314,904
Internal Medicine $314,904
Dr. Kevin Thomas, Md, MD
Internal Medicine — Payments: $294,767
Internal Medicine $294,767
Dr. Manesh Patel, M.d, M.D
Internal Medicine — Payments: $289,122
Internal Medicine $289,122
Dr. Camille Frazier-Mills, M.d, M.D
Internal Medicine — Payments: $187,940
Internal Medicine $187,940